Kalray (ALKAL) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
6 Jun, 20252024 financial performance
Reported 2024 revenue of €24.8M, nearly matching 2023's €25.8M, with a stronger second half.
85% of revenue came from the Enterprise segment (Ngenea), 15% from Acceleration Card sales.
Geographic revenue split: 49% US, 42% Europe (including UK), 9% rest of world.
EBITDA expected at approximately -€8M, impacted by lower margins and investments in the Dolomites processor.
Cost reduction plan initiated in September 2024 partially offset negative impacts.
Strategic asset disposal
Completed sale of the Data Acceleration Platform (Ngenea) business unit to DataCore Software.
Transaction value up to $20M: $12.5M upfront, $2.5M service contract, up to $5M earn-out based on 2025 performance.
Sale included all related assets and about 80 employees.
Proceeds to repay €3M BNP Paribas credit line and cover €1.5M in restructuring and transaction costs.
Financial outlook and liquidity
Cash horizon remains unchanged, with funding visibility until March 1, 2025.
Ongoing discussions with partners and suppliers to extend financial visibility.
Update on liquidity extension efforts expected by end of February 2025.
Latest events from Kalray
- Revenue stable at €24.8M, EBITDA -€8M, and Data Acceleration Platform sold for up to $20M.ALKAL
H2 2024 TU - Revenue quadrupled on a comparable basis, with EBITDA turning strongly positive in 2025.ALKAL
H2 2025 TU - 58% revenue growth and positive EBITDA in H1 2026, with strong outlook for FY2026.ALKAL
H1 2026 TU - First-ever positive EBITDA and free cash flow achieved, with double-digit growth expected in 2026.ALKAL
H2 2025 - Turnaround to positive EBITDA and cash flow, with improved margin and secured liquidity through September 2026.ALKAL
H1 2025 - Semiconductor growth and strategic refocus drive improved profitability outlook for 2025.ALKAL
H1 2025 TU - Strategic pivot and cost cuts target break-even by end-2025 after a challenging H1 2024.ALKAL
H1 2024 - Strong H2 growth expected as Kalray ramps up a €100M contract and finalizes Pliops deal.ALKAL
H1 2024 TU - Net loss widened to €23.3M in FY2024 as Kalray divested a major business unit and refocused strategy.ALKAL
H2 2024